Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 12.55M $66.89M Dec. 31, 2013
FMR 6.17M $32.89M Dec. 31, 2013
Baker Bros. Advisors 4.20M $22.39M Dec. 31, 2013
Broadfin Capital 4.00M $21.32M Dec. 31, 2013
Tudor Investment Corporation 2.34M $12.49M Dec. 31, 2013
BlackRock Fund Advisors 2.33M $12.43M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.92M $10.24M Dec. 31, 2013
Vanguard 1.47M $7.80M Dec. 31, 2013
Highland Capital Management 1.47M $7.82M Dec. 31, 2013
Deerfield Management Company 1.04M $5.60M March 31, 2013
STATE STREET CORPORATION 884181 $4.71M Dec. 31, 2013
Wellington Management Company 883134 $4.44M Sept. 30, 2013
NORTHERN TRUST 856489 $4.57M Dec. 31, 2013
Taconic Capital Advisors 785982 $3.95M Sept. 30, 2013
MORGAN STANLEY 722245 $3.85M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 710364 $3.79M Dec. 31, 2013
Franklin Resources 636816 $3.39M Dec. 31, 2013
Phocas Financial 625073 $3.33M Dec. 31, 2013
Jay G. Goldman 615000 $3.36M Dec. 31, 2010
Sandgrain Advisors 600000 $3.71M March 31, 2011
Kingdon Capital Management 580000 $2.58M June 30, 2013
Inves 568708 $5.56M June 30, 2012
Deutsche Bank Aktiengesellschaft 500620 $2.51M Sept. 30, 2013
D. E. Shaw & Co 406763 $2.17M Dec. 31, 2013
CITADEL ADVISORS 397254 $1.77M June 30, 2013
GOLDMAN SACHS 393352 $1.75M June 30, 2013
SuttonBrook Capital Management 392250 $3.35M Dec. 31, 2011
UBS AG 339710 $978364 Sept. 30, 2012
BOGLE INVESTMENT MANAGEMENT L P /DE/ 338411 $1.70M Sept. 30, 2013

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors March 31, 2011 585061 $3.62M
Trellus Management Company March 31, 2011 542630 $3.35M